Elizângela Gonçalves Schemitt

Dr. Elizângela Gonçalves Schemitt

Laboratory of Experimental Hepatology and Gastroenterology, Hospital de Clínicas de Porto Alegre
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in World Journal of Gastroenterology
Verified
Journal Article
Open access
JCJosieli Raskopf Colares
Josieli Raskopf Colares
ESElizângela Gonçalves Schemitt
Elizângela Gonçalves Schemitt
RHRenata Minuzzo Hartmann
Renata Minuzzo Hartmann
FLFrancielli Licks
Francielli Licks
MSMariana Do Couto Soares
Mariana Do Couto Soares
NMNorma Possa Marroni
Norma Possa Marroni
To evaluate the effects of melatonin (Mel) on oxidative stress in an experimental model of bile duct ligation (BDL). Male Wistar rats (n = 32, weight ± 300 g) were allocated across four groups: CO (sham BDL), BDL (BDL surgery), CO + Mel (sham BDL and Mel administration) and BDL + Mel (BDL surgery and Mel administration). Mel was administered intraperitoneally for 2 wk, starting on postoperative day 15, at a dose of 20 mg/kg. Mel was effective at the different standards, reestablishing normal liver enzyme levels, reducing the hepatosomatic and splenosomatic indices, restoring lipoperoxidation and antioxidant enzyme concentrations, reducing fibrosis and inflammation, and thereby reducing liver tissue injury in the treated animals. The results of this study suggest a protective effect of Mel when administered to rats with secondary biliary cirrhosis induced by BDL.

1 June 2019 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
RTRutiane Ullmann Thoen
Rutiane Ullmann Thoen
NBNathaniele Nebel Barther
Nathaniele Nebel Barther
ESElizângela Gonçalves Schemitt
Elizângela Gonçalves Schemitt
SBSílvia Bona
Sílvia Bona
SFSabrina Fernandes
Sabrina Fernandes
MPMarilene Porawski
Marilene Porawski
Rates of obesity have been growing at alarming rates, compromising the health of the world population. Thus, the search for interventions that address the metabolic repercussions of obesity are necessary. Here we evaluated the metabolic and antioxidant effects of zinc and branched-chain amino acids (BCAA) supplementation on obese rats. Male Wistar rats were fed either a high-fat/high-fructose diet (HFD) or a standard diet (SD) for 19 weeks. From the fifteenth week until the end of the experiment, HFD- and SD-fed rats received zinc (6 mg/kg) or BCAA (750 mg/kg) supplementation. Body weight, abdominal fat, lipid profile, blood glucose, insulin, leptin, and hepatic transaminases were evaluated. In the liver, superoxide dismutase and catalase activities and lipid peroxidation were also analyzed. HFD-fed animals showed increased weight gain, abdominal fat pad, plasma insulin, leptin, and triglycerides levels in comparison with SD-fed rats. Zinc supplementation reduced all these parameters, suggesting a beneficial role for the treatment of obesity. BCAA, on the other hand, did not show any beneficial effect. Liver antioxidant enzymes and hepatic transaminases plasma levels did not change among groups. Lipid peroxidation was higher in HFD-fed rats and was not reverted by zinc or BCAA supplementation. In conclusion, zinc supplementation may be a useful strategy for the treatment of the metabolic dysfunction associated with obesity.

1 December 2019 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ÉPÉder Ricardo Petry
Éder Ricardo Petry
DDDiego de Freitas Dresch
Diego de Freitas Dresch
CCClarice Carvalho
Clarice Carvalho
PMPatricia Calçada Medeiros
Patricia Calçada Medeiros
TRTatiana Gomes Rosa
Tatiana Gomes Rosa
CWClóvis Milton Duval Wannmacher
Clóvis Milton Duval Wannmacher

27 March 2019 in World Journal of Hepatology
Verified
Journal Article
Open access
ESElizângela Gonçalves Schemitt
Elizângela Gonçalves Schemitt
RHRenata M Hartmann
Renata M Hartmann
JCJosieli R Colares
Josieli R Colares
FLFrancielli Licks
Francielli Licks
JSJéferson O Salvi
Jéferson O Salvi
NMNorma P. Marroni
Norma P. Marroni
Protective action of glutamine in rats with severe acute liver failure

1 February 2019 in Experimental and Molecular Pathology
Verified
Journal Article
Closed access
COCristian Augusto Ostjen
Cristian Augusto Ostjen
CRCarlos Gustavo Sakuno Rosa
Carlos Gustavo Sakuno Rosa
RHRenata Minuzzo Hartmann
Renata Minuzzo Hartmann
ESElizângela Gonçalves Schemitt
Elizângela Gonçalves Schemitt
JCJosieli Raskopf Colares
Josieli Raskopf Colares
NMNorma Possa Marroni
Norma Possa Marroni

18 June 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GRGraziella Rodrigues
Graziella Rodrigues
AMAndrea Janz Moreira
Andrea Janz Moreira
SBSilvia Bona
Silvia Bona
ESElizângela Gonçalves Schemitt
Elizângela Gonçalves Schemitt
CMCláudio Augusto Marroni
Cláudio Augusto Marroni
NMNorma P. Marroni
Norma P. Marroni
Objective. In this study, we evaluated the efficacy of simvastatin in the treatment of nonalcoholic steatohepatitis induced by methionine and choline-deficient diet in mice and its possible effect on factors involved in the pathogenesis of the disease including oxidative stress and endoplasmic reticulum stress. Method. Male C57BL6 mice were fed either a normal diet (control) or a methionine and choline-deficient diet for four weeks and then treated orally with simvastatin (4 mg/kg once a day) for two final weeks. At the end of the experimental period, liver integrity, biochemical analysis, hepatic lipids, histology, DNA damage, biomarkers of oxidative stress, and endoplasmic reticulum stress were assessed. Results. Simvastatin treatment was able to significantly reduce hepatic damage enzymes and hepatic lipids and lower the degree of hepatocellular ballooning, without showing genotoxic effects. Simvastatin caused significant decreases in lipid peroxidation, with some changes in antioxidant enzymes superoxide dismutase and glutathione peroxidase. Simvastatin activates antioxidant enzymes via Nrf2 and inhibits endoplasmic reticulum stress in the liver. Conclusions. In summary, the results provide evidence that in mice with experimental nonalcoholic steatohepatitis induced by a methionine and choline-deficient diet, the reduction of liver damage by simvastatin is associated with attenuated oxidative and endoplasmic reticulum stress.